January 4, 2013 | The Wellcome Trust has started an investment arm with 200 million pounds ($326 million) of initial capital for biotech. Syncona Partners will support new businesses in the medical-device, therapeutics, diagnostics and information-technology industries. Long-term investments will amount to 1 million pounds to 20 million pounds each. Bloomberg